The broad function of the amygdala is to integrate and process information from external stimuli and coordinate appropriate behavioral outputs[@R1]--[@R3]. These complex functions are differentially regulated by the 11--15 distinct functional subnuclei of the amygdala, which make numerous connections with multiple cortical and subcortical brain regions. These subnuclei can also be grouped together according to a variety of criteria including connectivity, function and neuronal diversity. The most studied of these nuclear groups is the basolateral complex, which comprises the lateral, basolateral and basomedial nuclei. The prime function of the basolateral complex is the processing and storage of information with emotional salience, especially fear. In contrast, the function of the medial nucleus, via connections with the olfactory bulb and hypothalamus, is to integrate chemosensory and hormonal signals to control social, reproductive, feeding and defensive behaviors. The importance of the amygdala in human behavior is evidenced by the fact that amygdala dysfunction is a key component of numerous prevalent human disorders such as autism and autism spectrum disorders as well as stress related psychological disorders such as post - traumatic stress disorder (PTSD)[@R4]--[@R6]. Thus, unraveling the development of this complex structure is an important goal with potential translational applications.

The unique connectivity and complex nuclear organization of the amygdala sets it apart from all other telencephalic structures, most notably from laminar brain structures such as the cerebral cortex and hippocampus. In addition to classification according to functional criteria, individual amygdala nuclei have also been grouped based on whether their principal output neurons are excitatory (glutamatergic) or inhibitory (GABAergic)[@R1]--[@R3]. Major excitatory nuclei include the basolateral complex and cortical nuclei and major inhibitory nuclei include the central and medial nuclei. Although differing in their neuronal composition, both excitatory and inhibitory nuclei are also comprised of a variety of functionally diverse interneuron subtypes that are essential for the proper regulation of the firing of the output neurons. The coordinated development of these neuronal cell types during embryogenesis is essential for the formation of complex amygdala circuitry. However, despite its central role in normal and abnormal brain function and behavior, little is currently known regarding how neuronal cell diversity is generated in the amygdala.

In this study we examined the contribution of progenitor cells to excitatory and inhibitory cell diversity in the mature amygdala. Previous work from our laboratory, as well as others, has indicated that the pallial-subpallial boundary (PSB) of the telencephalon, the region of the telencephalon where pallial (e.g. high *Pax6, Ngn2*) and subpallial (e.g. *Gsh2, Dlx1/2*) gene expression abuts, is a major source of amygdala neural progenitors[@R7]--[@R10]. In addition to expressing regional markers, the pallial and subpallial aspects of the PSB express a unique combination of genes that includes the homeodomain transcription factor, *Dbx1*, which marks the ventral pallial (VP) progenitors of the PSB[@R9],[@R11]--[@R13]. In addition to the PSB, *Dbx1* is expressed in other progenitor regions of the developing telencephalon such as the preoptic area (POA) and septum. While a previous study has revealed that *Dbx1*-derived progenitors, specifically from the PSB and septum, contribute early born Cajal-Retzius cells to the piriform and cerebral cortices[@R11], whether this progenitor population contributes to amygdala cell diversity remains unexplored.

Using a combination of mouse genetic fate mapping, *in vitro* migratory assays and electrophysiological approaches, we find that the VP *Dbx1*+ progenitor pool is a source of excitatory neurons in the basolateral complex and cortical nuclei, the primary excitatory output nuclei of the amygdala. In addition, we uncover a novel migratory route, termed the PAS (POA-amygdala migratory stream), composed of *Dbx1*-derived cells from the POA to the emerging amygdala. Our electrophysiological analysis indicates that this migratory population gives rise to a remarkably restricted functional subclass of inhibitory neurons specifically in the mature medial amygdala nucleus. These inhibitory neurons are also characterized by their unique morphology and expression of inhibitory neuronal markers, such as neuronal nitric oxide synthase (nNOS), which together with their electrophysiological characteristics, distinguish them from other known telencephalic inhibitory neuron subclasses. Thus, our data reveal that spatially distinct telencephalic *Dbx1*+ progenitor pools are major sources of neuronal diversity for distinct nuclei of the mature amygdala, and therefore reveal a novel relationship between genetically marked progenitor pools and their limbic system fate.

RESULTS {#S1}
=======

Expression of *Dbx1* and generation of CreER^T2^ knock-in mice {#S2}
--------------------------------------------------------------

Previous studies have revealed that the pallial-subpallial boundary (PSB) is comprised of progenitors from the ventral pallium (VP) and dorsal LGE (dLGE) and is also the source of lateral cortical stream (LCS) migratory route to the amygdala[@R7],[@R8],[@R13]. Expression of the homeodomain transcription factor, *Dbx1*, marks VP progenitors as well as the developing septum and preoptic area (POA) from embryonic day (E) 9.5 to E14.5 ([Fig. 1a,b](#F1){ref-type="fig"} and data not shown)[@R9],[@R12]. The *Dbx1* expressing region in the POA is also positive for *Foxg1*[@R14], indicating that this population is of telencephalic rather than the diencephalic origin ([Fig. 1c,d](#F1){ref-type="fig"}).

To examine the fate of *Dbx1*+ cells, we used a genetic fate mapping approach in which an IRES-CreER^T2^ cassette was inserted into the 3' UTR region of *Dbx1* gene ([Fig. 1g](#F1){ref-type="fig"}, see material and methods). This strategy allows for the indelible marking of genetically defined progenitor populations from embryogenesis to adulthood, and thus is a powerful tool to track the fate of specific progenitor populations[@R15],[@R16]. Our analysis of *Dbx1*^+/*CreERT2*^ embryos reveals that *cre* is expressed in the same pattern as *Dbx1* ([Fig. 1e,f](#F1){ref-type="fig"} and data not shown) and insertion of an IRES-CreER^T2^ cassette into the 3' UTR of the *Dbx1* locus also importantly does not appear to interfere with normal *Dbx1* expression ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"})[@R11].

*Dbx1*-derived cells contribute to the post-natal amygdala {#S3}
----------------------------------------------------------

To examine the fate of *Dbx1*-derived cells in the amygdala, *Dbx1*^+/*CreERT2*^ mice were crossed to *R26RLacZ* reporter animals that permanently express β-galactosidase upon Cre-induced recombination[@R17]. The fusion of Cre to the tamoxifen-sensitive estrogen receptor (ER^T2^) allows Cre translocation to the nucleus to be controlled by the administration of tamoxifen, with recombination typically occurring 6--12 hours after tamoxifen delivery.[@R18] Pregnant dams were administered tamoxifen at E9.5, E10.5, E11.5, or E12.5 and the distribution of β-galactosidase-labeled cells was examined at post-natal day (P) 21 in both the telencephalon and diencephalon ([Fig. 2](#F2){ref-type="fig"} and [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}). Tamoxifen administration at E9.5 results in recombined cells mainly in the medial amygdala nucleus, with a few recombined cells observed in the cortical nucleus and none in the basolateral complex (lateral, basolateral and basomedial nuclei) ([Fig. 2b,g,l](#F2){ref-type="fig"}). However, tamoxifen administration one day later at E10.5 ([Fig. 2c,h,m](#F2){ref-type="fig"}) or two days later at E11.5 ([Fig. 2d,i,n](#F2){ref-type="fig"}), results in recombined cells in the basolateral complex, cortical and medial nuclei. In contrast, tamoxifen delivery at E12.5 results in recombined cells primarily in the basolateral complex with only a few recombined cells detected in the medial and cortical nuclei ([Fig. 2e,j,o](#F2){ref-type="fig"}) These data indicate that *Dbx1*+ progenitors generate cells destined for the amygdala in two waves; medial and cortical nuclei cells first (starting at approximately E10.0), then, approximately one day later, cells of the basolateral complex.

Origins of amygdala *Dbx1*-derived cells {#S4}
----------------------------------------

As *Dbx1* is expressed in multiple domains in the embryonic telencephalon we examined the origins of *Dbx1*-derived cells by analyzing patterns of putative migratory pathways in two sets of transgenic mice in which *Dbx1*+ progenitors and their progeny are marked: previously generated *Dbx1*^+/LacZ^ mice in which LacZ was knocked into the *Dbx1* locus[@R19] and the above described *Dbx1*^+/*CreERT2*^;*R26RLacZ* mice ([Fig. 3](#F3){ref-type="fig"}). Analysis of *Dbx1*^+/LacZ^ embryos at E13.5 reveals cohorts of LacZ+ cells along the LCS migratory route from the VP to the basal telencephalon ([Fig. 3a,b](#F3){ref-type="fig"}). In addition, we detect a large novel putative migratory route between the POA and the developing amygdala, which we term the "PAS" (POA-amygdala migratory stream) ([Fig. 3b,c](#F3){ref-type="fig"}).

Similar patterns of putatively migrating LacZ+ recombined cells are also observed in *Dbx1*^+/*CreERT2*^;*R26RLacZ* embryos ([Fig. 3d--f](#F3){ref-type="fig"}). As revealed by *Foxg1* expression, the PAS appears to originate within the telencephalon as opposed to the diencephalon ([Fig. 3g--i](#F3){ref-type="fig"}). Most strikingly, the overwhelming majority of *Dbx1*+ and *Dbx1*-derived cells accumulate in the region of the developing amygdala. Therefore, based on these patterns of LacZ expression in two sets of mice that mark *Dbx1*-expressing cells and their progeny it appears that two spatially separated *Dbx1*+ progenitor regions, the VP and POA, are the likely primary sources of the post-natal *Dbx1*-derived amygdala cells shown in [Fig. 2](#F2){ref-type="fig"}.

To more closely examine the patterns of putative migration from these sources, *Dbx1*^+/CreERT2^ mice were also crossed to *R26RYFP* reporter mice, which express yellow fluorescent protein (YFP) in the presence of Cre-recombinase[@R20] ([Fig. 4](#F4){ref-type="fig"}). In contrast to β-galactosidase, YFP is typically expressed in the entire cell, which allows for examination of migratory profiles. Tamoxifen treatment at E9.5 results in recombined cells emanating from the POA, with leading processes primarily oriented toward the basal telencephalon ([Fig. 4a--c](#F4){ref-type="fig"}). Interestingly, at this age of tamoxifen delivery only a few YFP+ cells can be detected along the LCS. In contrast, E10.5 tamoxifen treatment results in numerous YFP+ cells along the LCS, as well as a continued putative migration from the region of the POA ([Fig. 4d--i](#F4){ref-type="fig"}). Surprisingly, many of the *Dbx1*-derived cells of the LCS do not express Pax6, a pallial marker typically expressed in many cells of the LCS[@R8]. The leading processes of many of POA-derived and LCS recombined cells were oriented toward the basal telencephalon suggestive of active migration to the developing amygdala. Notably, the orientation of the leading processes of the *Dbx1*-derived POA population appeared different from that of *Dbx1*-derived cells along the LCS, indicating that these are two separate migratory populations ([Fig. 4d,e](#F4){ref-type="fig"}).

Thus, our analysis of patterns of LacZ and YFP expression in a series of mice in which *Dbx1*+ cells and their progeny are marked ([Fig. 3](#F3){ref-type="fig"} and [Fig. 4](#F4){ref-type="fig"}) indicate that the post-natal *Dbx1*-derived cells in the amygdala ([Fig. 2](#F2){ref-type="fig"}) primarily originate in the VP and POA. These analyses also reveal that *Dbx1*-derived cells of the POA are generated earlier in development than the *Dbx1*-derived cells of the VP. This also correlates with the one-day difference in the timing of the generation of *Dbx1*-derived medial nuclei cells versus *Dbx1*-derived basolateral complex cells as shown in [Fig. 2](#F2){ref-type="fig"}.

POA-derived cells are highly migratory {#S5}
--------------------------------------

While the above studies suggest that *Dbx1*-derived cells of the POA migrate to the developing amygdala, we wanted to directly examine and compare their migratory capacity to that of the PSB and septum, the two other telencephalic domains of *Dbx1*+ expression ([Fig. 1](#F1){ref-type="fig"}). First, the POA, PSB and septum were dissected from E12.5 embryos and cultured for three days *in vitro* (DIV) in matrigel, a permissive substrate for migration ([Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}). The majority (17/21) of POA explants exhibit moderate to robust migration ([Supplementary Fig 3a,b](#SD1){ref-type="supplementary-material"}). This is in contrast to explants from the septum, from which either no or minimal migration is observed ([Supplementary Fig. 3c](#SD1){ref-type="supplementary-material"}). Consistent with our previous studies[@R8], most (14/16) PSB explants also display robust migration ([Supplementary Fig. 3d](#SD1){ref-type="supplementary-material"}).

Second, we also carried out a series of DiI experiments in telencephalic slices from *Dbx1*^+/CreERT2^;*R26RYFP* embryos at E13.5 ([Fig. 5](#F5){ref-type="fig"}). After two days *in vitro*, numerous DiI+ cells from the POA and PSB migrate toward the region of the developing amygdala ([Fig. 5a,b,f,g](#F5){ref-type="fig"}). Many DiI+ cells from both the PSB and POA also express YFP ([Fig. 5c--e, h--m](#F5){ref-type="fig"}), revealing that these migratory streams were comprised, at least in part, of *Dbx1*-derived cells. Interestingly, the PAS is also marked by expression of *Dlx2*^+/tauLacZ^ and *Lhx2*, suggesting that this novel migratory route is comprised of a heterogeneously marked population of cells ([Fig. 5n--o](#F5){ref-type="fig"}). Although their mode of migration remains to be fully elucidated, *Dbx1*-derived cells of the POA also intermingle with RC2+ radial glia, suggesting that these cells may migrate along radial glia ([Supplementary Fig. 4](#SD1){ref-type="supplementary-material"}).

Fate of *Dbx1*-derived cells in the post-natal amygdala {#S6}
-------------------------------------------------------

Based on their location in the pallium and subpallium respectively, we predicted that VP *Dbx1*-derived cells give rise to amygdala excitatory neurons and the POA *Dbx1*-derived cells give rise to amygdala inhibitory neurons. To test this, we examined if *Dbx1*-derived cells from these locations express regional neuronal subtype markers. In these experiments, sections from E12.5 *Dbx1*^+/CreERT2^;*R26RYFP* embryos in which tamoxifen was administered at E10.5 were double immunolabeled with a variety of well-characterized cell specific markers including Tbr1, a marker of developing and mature telencephalic excitatory neurons[@R21], and calbindin and Dlx2, broad markers of developing inhibitory neurons[@R22],[@R23] ([Fig. 6](#F6){ref-type="fig"}). Consistent with their pallial origin, numerous *Dbx1*-derived cells of the LCS express Tbr1 (90.2%), but do not express calbindin ([Fig. 6a--n](#F6){ref-type="fig"}). In contrast, *Dbx1*-derived cells of the PAS do not express Tbr1 ([Fig. 6a--g](#F6){ref-type="fig"}), but instead many express the subpallial markers calbindin (41.4%) or Dlx2 (80.8%) ([Fig. 6h--r](#F6){ref-type="fig"}). Thus, it appears that *Dbx1*-derived cells of the VP generate amygdala excitatory neurons and *Dbx1*-derived cells of the PAS differentiate into inhibitory neurons.

We next examined the post-natal cellular fate of *Dbx1*-derived cells in the amygdala. Tbr1 was used to mark excitatory cells, and based on previous studies of amygdala neuronal cell diversity, neuronal nitric oxide synthase (nNOS), calretinin and calbindin were used to mark mature inhibitory neurons[@R24],[@R25]. Our analyses reveals that all *Dbx1*-derived cells in the basolateral complex and most (95.3%) of the cells in the cortical nucleus are Tbr1+ ([Fig. 7a,b,d,e](#F7){ref-type="fig"}). In contrast, none of the recombined cells in the medial nucleus, a region only sparsely populated by excitatory neurons, are Tbr1+ ([Fig. 7c,f](#F7){ref-type="fig"}). Instead, most (78.6%) of the recombined cells of the medial amygdala express nNOS, a marker of medial nuclei projection neurons[@R26] ([Fig. 7g--i,p](#F7){ref-type="fig"}). In addition, 50.8% of YFP+ cells in the medial nucleus express calbindin and 19.1% express calretinin ([Fig. 7j--p](#F7){ref-type="fig"}), consistent with an inhibitory neuronal fate. Thus, *Dbx1*-derived cells give rise to both excitatory and inhibitory cell diversity in the post-natal amygdala.

Collectively, these results indicate that the *Dbx1*-derived cells of the VP and POA are major differential sources of this excitatory and inhibitory cell diversity in the basolateral complex/cortical nuclei and medial nuclei, respectively, in the post-natal amygdala. The evidence in support of this is three-fold: 1) the *Dbx1*-derived cells of the POA are generated one day earlier than those of the VP (shown in [Fig. 4](#F4){ref-type="fig"}). This correlates with the one day earlier generation of *Dbx1*-derived cells in the mature medial nucleus as compared to the basolateral complex (shown in [Fig. 2](#F2){ref-type="fig"}), 2) the leading processes of VP and POA *Dbx1*-derived cells are oriented toward the developing amygdala indicating that these two regions are separate sources of migrating cells (shown in [Fig. 4](#F4){ref-type="fig"}), and 3) during their migration to the developing amygdala, VP and POA *Dbx1*-derived cells express excitatory and inhibitory neuronal markers, respectively (shown in [Fig. 6](#F6){ref-type="fig"}).

Physiological analysis of *Dbx1*-derived medial nuclei cells {#S7}
------------------------------------------------------------

In addition to expressing unique combinations of immunomarkers, subtypes of telencephalic inhibitory neurons also have distinct electrophysiological signatures[@R34]. To determine if *Dbx1*-derived neurons possess functional features of inhibitory neurons, we carried out whole cell patch clamp recordings of recombined YFP+ cells in the medial nucleus from *Dbx1*^+/*CreERT2*^;*R26RYFP* mice at P17--27 ([Fig. 8](#F8){ref-type="fig"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). YFP+ neurons in the medial amygdala were identified under fluorescent and infrared differential interference contrast (IR-DIC) video microscopy ([Fig.8a--c](#F8){ref-type="fig"}). The average *Dbx1*-derived neuron has a membrane potential of −58.21 ± 1.1 mV (n=35) with an input resistance at 491.34 ± 26.7 MΩ (n=35). Action potential discharge patterns were obtained by injecting current pulses in current clamp mode and monitoring discharge responses. A remarkable feature of *Dbx1*-derived neurons is the lack of diversity in action potential firing patterns as all (n=35) recorded cells exhibit accommodating firing patterns (accommodation ratio = 0.568 ±0.029) at threshold and all have sharp rising after hyperpolarizing potentials ([Fig. 8d--f](#F8){ref-type="fig"}). In addition, *Dbx1*-derived neurons share some biochemical and physiological similarities with inhibitory neurons in other brain regions. For example, although there are differences in many characteristics, the firing pattern is similar to the recently identified nNOS+ "Ivy cells" of the hippocampus[@R27] and the calretinin+ classic-accommodating "Martinotti cells" of the cerebral cortex[@R28]. Additionally, at hyperpolarizing current pulses in the −100pA range, *Dbx1*-derived neurons reveal a small sag (4.1 ± 0.55 mV n=27) indicative of an Ih current, and at the conclusion of the 600 ms hyperpolarizing pulse, cause a rebound burst indicative of low threshold calcium currents in the inhibitory low threshold spiking cells of the cerebral cortex[@R29]--[@R31]. Current pulses at more negative levels are deleterious to the cells and result in rapid depolarization in membrane potential. As revealed by biocytin filling, *Dbx1*-derived cells possess large sparsely spiny proximal dendrites with numerous long typically bipolar oriented projections ([Fig. 8g--i](#F8){ref-type="fig"} and [Supplementary Fig. 5](#SD1){ref-type="supplementary-material"}). This morphology is similar to recently characterized medial amygdala neurons, some of which displayed inhibitory characteristics[@R32]. Therefore, a combination of immunomarker, electrophysiological and morphological analyses ([Fig. 7](#F7){ref-type="fig"} and [Fig. 8](#F8){ref-type="fig"}) indicate that *Dbx1*-derived neurons, while sharing similarities with a variety of classic inhibitory features outside of the amygdala, appear to be a distinct subclass of neurons.

DISCUSSION {#S8}
==========

By a combination of *in vivo* and *in vitro* approaches, including genetic fate mapping, cell migration assays and electrophysiology, we examined the link between the embryonic origin of progenitor cells and their fate in the mature amygdala. Our primary finding is the identification of a novel neural progenitor pool specifically dedicated to the generation of a single subtype of inhibitory neuron in the mature medial amygdala nucleus, a major inhibitory output nucleus of the amygdala. Our results reveal that this population, which is marked by the expression of the homeodomain encoding gene *Dbx1*, migrates along a newly identified migratory stream, the PAS, which arises from the preoptic area (POA) of the subpallial telencephalon, a region previously not recognized as a source of migratory cells. Moreover, our analyses indicate that the ventral pallial (VP) *Dbx1*+ population is a source of excitatory neurons in the basolateral complex and cortical nuclei, the two major excitatory nuclei of the amygdala (Schematic shown in [Supplementary Fig. 6](#SD1){ref-type="supplementary-material"}). These findings also provide strong support for an emerging model in which aspects of the program for the development of the amygdala are distinct from that of other telencephalic structures such as the cerebral cortex.

The POA is a novel source of amygdala inhibitory neurons {#S9}
--------------------------------------------------------

The embryonic subpallium is the origin of most, if not all, inhibitory neuronal cell populations in the cerebral cortex and striatum[@R33]-- [@R35]. It also appears that the vast inhibitory interneuronal diversity that is characteristic of the telencephalon is derived from spatially distinct progenitor pools within the subpallial ganglionic eminences, most prominently the medial (MGE) and caudal (CGE) ganglionic eminences. Emerging evidence also suggests that the genetic mechanisms for establishment of inhibitory neuronal cellular diversity in the telencephalon is strikingly similar to that in the spinal cord in which the combinatorial expression of specific transcription factor genes (typically of the homeodomain and bHLH classes) intrinsically instruct spatially separate progenitor populations to give rise to mature neurons with differential functional fates[@R34],[@R36]. Based on this idea of 'combinatorial genetic codes', recent studies have revealed that the subpallium can be subdivided into at least 18 distinct progenitor zones[@R37]. One of these unique regions is the POA, which is distinguished in part by its focal expression of *Dbx1*. By use of a Cre-based fate mapping strategy combined with *in vitro* migratory assays, we identify a novel POA migratory stream termed the "POA-amygdala stream (PAS)" that is comprised, at least in large part, of *Dbx1*-derived progenitors. As the POA and PAS is also combinatorially marked by a number of other transcription factors, most notably *Nkx6.2, Lhx2* and *Dlx1/2*([@R37] and data shown here), it is likely that similar to the lateral cortical stream (LCS) migratory route from the PSB, the PAS may be comprised of a diverse set of progenitor cells.

The primary function of the medial amygdala is to process sensory information from the olfactory bulb and relay this information the hypothalamus, a brain region involved in hormonal regulation. As such, the medial amygdala has reciprocal connections with multiple hypothalamic nuclei, which in turn project to numerous regions of the brainstem. These pathways are involved in the regulation of social, feeding and reproductive behaviors[@R3],[@R38]. Along with the central nucleus, the medial amygdala comprises the major inhibitory output of the amygdala. The predominant neuronal subtype of the medial amygdala is inhibitory projection neurons. Based on their electrophysiological properties, cellular morphology and expression of nNOS, the *Dbx1*-derived medial amygdala neurons resemble a previously characterized population of inhibitory projection neurons of the medial nucleus[@R26],[@R32]. Although their function remains unknown, these nNOS+ neurons project to the paraventricular nucleus of the hypothalamus, and therefore may be involved in the modulation of hormone release and autonomic responses. Thus, in addition to identification of a novel *Dbx1*-derived POA-amygdala migratory stream, our results indicate that these cells generate a specific subtype of inhibitory neurons in the medial amygdala, and therefore uncover a novel relationship between gene expression, developmental origin and electrophysiological fate in the amygdala.

Ventral pallial source of excitatory neurons {#S10}
--------------------------------------------

The PSB comprises progenitors from the VP and dLGE aspects of the developing telencephalon. These progenitors migrate to the basal telencephalic limbic system via the lateral cortical stream (LCS)[@R8],[@R39]. A series of studies has revealed that VP and dLGE progenitors express a combination of markers that define this region as distinct from other telencephalic progenitor domains[@R9]--[@R11],[@R40],[@R41]. Based on their expression of pallial markers, such as *Pax6*, the VP population is predicted to give rise to excitatory neurons. In contrast, dLGE progenitors, which express subpallial markers such as *Gsh2* and *Dlx1/2*, may generate subtypes of inhibitory neurons of the amygdala. However, to date a direct link between gene expression domains of the PSB and neuronal cell fate in the amygdala has not been demonstrated. Our data indicate that *Dbx1*+ progenitors derived from the VP are a source of excitatory neurons of basolateral complex and cortical amygdala nuclei, major excitatory outputs of the amygdala. During their migration along the LCS, a subpopulation of these basally-migrating *Dbx1*-derived cells express Tbr1, a marker of excitatory neurons, but, interestingly, do not express Pax6. As Pax6 expression marks a large number of LCS cells[@R8],[@R12],[@R13],[@R41],[@R42] this result was somewhat surprising, and indicates that the VP generates a heterogeneous pool of progenitors destined for the amygdala. In addition to the VP as a source of excitatory cells of the amygdala, fate mapping studies of *Emx1*-derived cells, whose expression marks more dorsally located progenitors in the lateral pallium (LP), are also a presumptive source of amygdala excitatory neurons[@R43],[@R44]. Whether these progenitor populations that are differentially marked by *Dbx1, Pax6* and/or *Emx1* give rise to distinct functional and or spatially located excitatory neurons in the mature amygdala remains to be explored.

Comparison of amygdala development to other brain regions {#S11}
---------------------------------------------------------

A number of recent studies have revealed there are notable similarities between development of the amygdala and other major telencephalic structures such as the cerebral cortex and striatum. The main commonality is a sharing of progenitor populations for the generation of neuronal diversity. For example, *in utero* cell transplantation fate mapping and gene expression studies have revealed that the medial (MGE) and caudal (CGE) ventral telencephalic ganglionic eminences are sources of inhibitory interneuronal cell diversity for the amygdala, cerebral cortex and striatum[@R45],[@R46]. In addition, recent genetic fate mapping studies have revealed that subpallial progenitors expressing *Nkx2.1* generate parvalbumin interneuronal subtypes in both the amygdala and cerebral cortex[@R47]. Moreover, the lateral olfactory tract nucleus (nLOT) of the amygdala appears to share a common developmental origin with the cerebral cortex[@R48].

However, our finding of a point-to-point correlation between the *Dbx1*-derived POA source and the medial nucleus of the amygdala suggests a putative additional and novel mechanism for the generation of neuronal cell diversity in the amygdala in which there also exists progenitor pools set aside exclusively for the limbic system. This is interestingly consistent with and predicted by previous molecular anatomical studies, which have identified combinations of genes whose expression marks both embryonic progenitor domains and individual emerging amygdala nuclei, including the medial and central nuclei, suggesting a developmental relationship between the two[@R9],[@R49]. A major prediction of these gene expression studies is that progenitor pools that express unique combinations of genes will generate distinct functional cell types. As revealed by our studies, at least in the case of the *Dbx1*-derived POA population, this progenitor pool gives rise almost exclusively to a single functional subtype of inhibitory neurons of the medial amygdala. Although possessing some characteristics in common with other telencephalic inhibitory cell types, by a combination of criteria including neuronal subtype marker expression, cell morphology and electrophysiological properties, the POA *Dbx1*-derived neurons of the medial amygdala appear to be distinct from other telencephalic inhibitory cell types. Therefore, our data, in conjunction with previous studies, suggest a model in which there are both overlapping and distinct mechanisms for amygdala development in comparison to other telencephalic structures. Thus, for the generation of cell types that are found in other brain regions (such as parvalbumin interneurons which are generated in the MGE), there are shared progenitor pools. In contrast, the generation of cell types that may be exclusive to the amygdala, such as the medial amygdala *Dbx1*-derived inhibitory neurons, appears to require the dedication of progenitor pools solely for the production of that cell type.

In summary, our data provide novel and important new insight into the developmental mechanisms underlying the generation of neuronal diversity in the amygdala, a brain structure essential for major aspects of complex mammalian behavior. First, we identify a new major migratory stream (the PAS) in the developing brain that is comprised of *Dbx1*+ progenitors derived from the POA. As this population generates a specific cell type in a distinct functional nucleus of the amygdala, we reveal a novel and remarkable direct correlation between an embryonic progenitor population and a functional neuronal cell type in the mature telencephalon. Second, our data reveal major differences between the logic for the development of the amygdala and the cerebral cortex, and thus present a revised model of brain development. In addition, as altered function of the amygdala is a hallmark characteristic of neuro-developmental disorders such as autism and autism spectrum disorders, our findings may provide a framework for a deeper understanding of the etiology of these disorders.

METHODS {#S12}
=======

Generation of CreER^T2^ knock-in mice {#S13}
-------------------------------------

All procedures involving the use of animals were carried out in accordance with approved procedures established by the Children's National Medical Center and Georgetown University Animal Care and Use Committees. The *Dbx1*^+/*CreERT2*^ targeting construct was generated by targeting an IRES-CreER^T2^-FRT-NEO-FRT into the BamHI site at the 3' UTR of the *Dbx1* locus (obtained from mouse 129sv strain RCPI 21 PAC library from Invitrogen Inc.), the same site previously used to knock *Cre* into the *Dbx1* locus[@R11]. Correctly targeted R1 ES cells were injected into C57BL/6 blastulas, and chimeric offspring were crossed to C57BL/6 mice. The Neomycin resistance gene was removed by crossing heterozygous *Dbx1*^+/*CreERT2*^ mice to FLPeR ("flipper") mice (Jackson Labs).

Reporter mouse lines and tamoxifen delivery {#S14}
-------------------------------------------

*R26RLacZ* and *R26RYFP* reporter mice were obtained from Jackson Labs. Tamoxifen (Sigma T5648) was dissolved at a concentration of 20mg/ml in corn oil (Sigma C8267) and administered by oral gavage to pregnant dams at a concentration of 4--8mg/40g mouse body weight.

Immunohistochemistry and LacZ staining {#S15}
--------------------------------------

Embryos were fixed with 4% paraformaldehide for 2hrs at 4□, dehydrated in 30% sucrose, embedded in OCT and sectioned at 30 µm. For detection of LacZ expression in *Dbx1*^+/LacZ^ knock-in, *Dbx1*^+/*CreERT2*^;*R26RLacZ* and *Dlx2*^+/tauLacZ^ embryos, sections were incubated in the X-gal staining solution overnight at 37□. For detection of Dlx2 expression, *Dbx1*^+/CreERT2^;*R26RYFP* mice were crossed to previously generated *Dlx2*^+/tauLacZ^ mice in which LacZ expression faithfully recapitulates *Dlx2* expression[@R50]. For immunohistochemistry, sections were incubated with the primary antibody at 4□ overnight, washed and incubated with the corresponding fluorescent secondary antibodies. Primary antibodies used were goat anti-β-galactosidase (1:400; Biogen), rabbit anti-Tbr1 (1:2000; kind gift from R. Hevner), rabbit anti-Pax6 (1:500; Covance Research Products), rabbit anti-nNOS (1:1000; Sigma), goat anti-GFP (to detect YFP expression, 1:500; Novus), rabbit anti-calbindin (1:500; Calbiochem), rabbit anti-calretinin (1:1000; Millipore) and mouse-anti RC2 (1:5; Developmental Hybridoma Studies Bank, University of Iowa, Iowa City, IA).

In situ hybridization {#S16}
---------------------

Embryos were processed and sectioned as described above. Sections were refixed with 4% PFA and subsequently treated with proteinase K, refixed with 4% PFA, treated with triethanolamine containing acetic anhydride and then hybridized with a digoxigenin-UTP-labeled RNA probes overnight. Next day, the probes were washed with 50% formamide, 2xSSC at 65 °C, treated with 20mg RNase and washed in 50% formamide, 2xSSC at 65 °C. Signals were detected with an anti-digoxigenin antibody (Roche) and BM purple (Roche). The probes used in this study were *Dbx1*[@R9] (probe used [Fig. 1](#F1){ref-type="fig"}), *Foxg1*[@R14], *Lhx2*[@R37] and *Cre* recombinase (5' coding region was subcloned into pBlusescript and RNA probe was generated from NcoI digested plasmid using T3 RNA polymerase). For analysis of *Dbx1* expression in *Dbx1*^+/CreERT2^ embryos ([Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}), a PCR amplified fragment of the 5' coding region was subcloned into pBluescript, and RNA probe was generated from BamHI digested plasmid using T7 RNA polymerase.

Migration assays {#S17}
----------------

For matrigel assays, tissue was dissected from E12.5 embryos using Lumsden Bioscissors. The explants were placed in matrigel (BD Biosciences) mixed with L-15 media and cultured in Neurobasal medium (Invitrogen), supplemented with penicillin/streptomycin (1:100; Invitrogen), B27 supplement (1:50; Invitrogen) and glutamine (1:100; Invitrogen). After 3 DIV, explants were fixed in 4% PFA for 30 min, rinsed briefly in PBS, covered with 50% glycerol and photographed. For DiI migration assays, the 300µm horizontal or coronal slices were made from E13.5 embryos with a vibratome and DiI crystals were placed in the POA or VP, and cultured in Neurobasal medium (Invitrogen), supplemented with penicillin/streptomycin (1:100; Invitrogen), B27 supplement (1:50; Invitrogen) and glutamine (1:100; Invitrogen). After taking low power pictures of both light field and fluorescence, specimens were fixed in 4% PFA for 2 hrs, re-sectioned on a vibratome at 100 µm and processed for immunofluorescence.

Electrophysiology and biocytin {#S18}
------------------------------

After sacrifice, brains of animals were immediately immersed in ice-cold - oxygenated (95% O~2~/ 5% CO~2~) sucrose solution (mM): 234 sucrose, 11 glucose, 24 NaHCO~3~, 2.5 KCl, 1.25 NaH~2~PO~4~\*H~2~O, 10 MgSO~4~ and 0.5 CaCl~2~. Coronal slices were cut on a vibratome (Leica) at 250 ⌠m and placed in preheated (32°C), oxygen equilibrated, artificial cerebral spinal fluid (ACSF) for 1 hour. Slices were then placed in a recording chamber and visualized with a fixed staged, upright microscope (Nikon, E600 FN) equipped with infrared (IR) illumination, Nomarski optics, an IR-sensitive video camera (COHU) and fluorescent lamp (Nikon) with a 450--490λ filter. Intracellular pipettes were pulled with a Flaming/Brown Micropipette Puller (Sutter Instruments) to a resistance of 3--5 MΩ when filled with a solution containing (mM): 130 K-gluconate, 10 KCl, 10 HEPES, 10 EGTA, and 2 MgCl~2~. YFP+ fluorescent cells were recorded at room temperature (21--23°C) with continuous perfusion of ACSF in current clamp mode (Multiclamp 700A, DigiDATA, Axon). After recording membrane potential and input resistance values, cells were categorized based on their response to depolarizing and hyperpolarizing current pulses. The response properties were analyzed off-line using pClamp software (Axon) and graphing software (Origin).

In some cases post recording biocytin (1%) was injected with depolarizing current pulses (1nA). Pictures were taken with an image capturing (Scion) system in order to relocate the cells post-processing. A subset of tissue with biocytin filled cells was also processed for nNOS immunohistochemistry. In these cases, slices the were removed from the recording chamber and fixed overnight in 4% paraformaldehyde and processed for immunohistochemistry.

Microscopy {#S19}
----------

Light microscopic photographs were taken using a Olympus BX51 microscope and a Olympus CKX41 inverted microscope. Fluorescent photographs were taken using Olympus BX61 (for low power fluorescence and low power DiI images), Zeiss Apotome (for high power fluorescence), a Zeiss LSM510 confocal microscope (for high power DiI/YFP double fluorescence) or an Olympus Fluoview Laser Scanning Confocal Microscope (for biocytin filled cells). Any brightness and contrast adjustments were done equally across pictures using Adobe Photoshop.
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![Expression of *Dbx1* and knockin approach\
Expression of *Dbx1* (**a,b**) and *Foxg1* (**c,d**) in wild-type embryos, and *Cre* (**e,f**) in *Dbx1*^+/CreERT2^ knock-in embryos, at E11.5 is shown at rostral and caudal levels in coronal sections. *Dbx1* is expressed in the septum (**a**, arrow), the ventral pallium (**b**, arrowhead) and the preoptic area (**b**, double arrowhead). *Foxg1* expression delineates the telencephalon from the diencephalon (**c, d**). Dotted lines in **b,d** indicate the telencephalic-diencephalic border. *Cre* expression recapitulates *Dbx1* expression in the septum (**e**, arrow), the ventral pallium (**f**, arrowhead) and the preoptic area (**f**, double arrowhead). Schematic of the knockin approach in which an IRES-CreER^T2^ cassette was inserted into the 3' UTR of the 4^th^ exon of *Dbx1* is shown in (**g**). *Abbr*: CGE; caudal ganglionic eminence, CTX; cerebral cortex, HIP; hippocampus, HYP; hypothalamus, MGE; medial ganglionic eminence SEP; septum (Note: Embryonic anatomy is based on^37^). Scale bar; 250 µm](nihms103095f1){#F1}

![*Dbx1*-derived cells in the post natal amygdala\
β-galactosidase staining of coronal sections from *Dbx1*^+/CreERT2^*;R26RLacZ* brains at P21 reveals numerous recombined LacZ+ cells in the amygdala. Distribution of recombined cells from tamoxifen (TM) administration at E9.5 (**b,g,l**), E10.5 (**c,h,m**), E11.5 (**d,i n**) or E12.5 (**e, j o**) are shown. Boxed area on schematics (**a, f, k**) indicate the region of the amygdala shown in each panel. E9.5 TM delivery results in recombined cells in the cortical and medial nuclei (**b,g,l,** arrowheads), but not the lateral and basolateral nuclei. In addition to the cortical and medial nuclei, TM delivery at E10.5 (**c,h,m**) or E11.5 (**d,i,n**) results in recombined cells in the lateral and basolateral nuclei. TM delivery at E12.5 results in recombined cells in the lateral and basolateral nuclei only (**e,j,o**). *Abbr*: BLA; basolateral nucleus, Co; cortical nucleus, HYP; hypothalamus, LA; lateral nucleus, MePD; medial nucleus posterior dorsal, MePV; medial nucleus posterior ventral. Scale bar; 500 µm](nihms103095f2){#F2}

![*Dbx1*-derived cells in the developing basal telencephalon\
β-galactosidase staining of coronal sections of E13.5 *Dbx1*^+/LacZ^ knock-in (**a-c**) and *Dbx1*^+/CreERT2^*;R26RLacZ* embryos (**d-f**) reveals putative migrating cells to the region of the developing amygdala. LacZ+ cells are shown along the both LCS (**a-f**, single arrow, inset in **d** shows a higher magnification of LacZ+ cells of the LCS) and the putative POA-amygdala migratory stream (PAS) (**b,c,e,f**, double arrows). *Foxg1* expression in corresponding sections in *Dbx1*^+/LacZ^ knock-in embryos (**g-i**) indicates that *Dbx1*-derived cells distributed along PAS are located within the telencephalon. Note the relative paucity of LacZ+ cells in the ganglionic eminences and the developing cerebral cortex. *Abbr*: LGE; lateral ganglionic eminence, POA; preoptic area, POH; preopto-hypothalamic region, TH; thalamus. Scale bar; 250 µm](nihms103095f3){#F3}

![Distribution of YFP+ recombined cells at embryonic stages\
Tamoxifen was administered to *Dbx1*^+/CreERT2^*;R26RYFP* embryos at E9.5 (**a-c**) or E10.5 (**d-i**) and analyzed at E12.5 as shown. E9.5 TM administration results in YFP+ recombined cells (green) primarily in the POA (asterisk), with only a few YFP+ recombined cells observed along the LCS as shown in a coronal section at low power magnification (**a**). Higher power magnification of areas highlighted by arrows in (**a**) shows leading processes of recombined cells (arrows,**b, c**). Numerous recombined cells are observed in the VZ of the POA (**c,** dotted line marks the edge of the tissue and the location of the lateral ventricle "v"). As shown in a low power coronal section (**d**), E10.5 TM administration (**d, g**) results in recombined cells along both the PAS migratory stream (arrow, **f**) and LCS (arrow, **e**). Higher power magnification shows Pax6 (red) negative, recombined cells along the LCS with migratory profiles directed toward the basal telencephalon (arrow, **e**). Recombined PAS cells also display migratory profiles directed toward the developing amygdala (arrow, **f**). The PAS migratory stream is most evident in horizontal sections (**g**, asterisk marks the POA), with higher power magnification of YFP+ cells also revealing recombined cells with leading processes oriented toward the developing amygdala (arrows, **h, i**). *Abbr*: AMY; developing amygdala, M-HB; midbrain-hindbrain region, PTH; prethalamus. Scale bar in (a) for (a, b, g); 250 µm. Scale bar in (i) for (b, c, e, f, h, i); 20 µm](nihms103095f4){#F4}

![Migration from the PSB and POA\
DiI crystals (red) were placed in either the PSB in coronal slices (**a, b**, n=2) or in the POA (**f, g**, n=4) in horizontal slices at E13.5 in *Dbx1^+/CreERT2^;R26RYFP* embryos treated with tamoxifen at E10.5. After two days in vitro (DIV), DiI labeled cells (red) from both the PSB and the POA migrate to the basal telencephalon (**b, g**). Boxed regions show that migratory streams from both the PSB (arrows, **c-e**) and POA (arrows, **h-j**) comprise *Dbx1*-derived cells as revealed by co-expression of DiI (red) and YFP (green). DiI and YFP co-expressing cells are also shown from another brain slice (arrows, **k-m**). β-galactosidase stained horizontal sections from E12.5 *Dlx2^+/^*^tauLacZ^ embryos (**n**) and *Lhx2* mRNA expression (**o**) also mark the PAS migratory route (double arrows, asterisk marks the POA in (**o**)). Scale bar in (a) for (a, b, f, g); 250 µm. Scale bar in (c) for (c-e, h-m); 50 µm. Scale bar in (n) for (n, o); 250 µm.](nihms103095f5){#F5}

![*Dbx1*-derived cells express regional cell fate markers during embryogenesis\
The expression of Tbr1 (**a-g**) and caldindin (**h-n**) in *Dbx1*^+/CreERT2^;*R26RYFP* embryos, and Dlx2 (**o-r**) in *Dbx1*^+/CreERT2^;*R26RYFP*; *Dlx2*^tauLacZ^embryos at E12.5 in which TM was administered at E10.5 is shown. As shown in a coronal section (**a**), expression of Tbr1 (red) is detected in 90.2% (46/51) of YFP+ recombined cells (green) along the LCS (boxed region "**b**" and arrows in **b-d** show double labeled cells). In contrast, Tbr1 is not detected in any (0/33) YFP+ recombined cells along the POA-amygdala migratory stream (PAS) (boxed region "**e**" and arrows in **e-g** show lack of double labeling). As shown in a horizontal section (**h**), no (0/88) YFP+ recombined cells (green) of the LCS co-express calbindin (red) (boxed region "**i**" and arrows in **i-k** show lack of double labeling). However, 41.4% (46/111) of YFP+ recombined cells of the PAS (green) co-express calbindin (red) (boxed region "**i**" and arrows in **l-n** show double labeled cells). As shown in a coronal section (**o**), 80.8% (21/26) of YFP+ recombined cells of the PAS (green) also co-express Dlx2 (red) (boxed region "**p**" and arrows in **p-r** show double labeled cells). Asterisks in **h** and **o** mark the POA. Scale bar in (o) for (a, h, o); 250 µm. Scale bar in (p) for (b-g, i-n, p-r); 20 µm](nihms103095f6){#F6}

![*Dbx1+* progenitors generate amygdala excitatory and inhibitory neurons\
The cellular phenotype of recombined cells in the amygdala was examined at P21 in *Dbx1*^+/CreERT2^;*R26RYFP* mice that were administered tamoxifen at E10.5. All (32/32) YFP+ recombined cells (green) in the basolateral complex (**a,d**) and 95.3% (41/43) of recombined cells in the cortical nucleus (**b,e**) are positive for Tbr1 (red) as shown at low and high power magnification (arrows show double labeled cells). In contrast, no (0/41) YFP+ recombined cells (green, arrow) in the medial nucleus express Tbr1 (arrowhead) (**c,f**). Higher power magnification of the medial nucleus reveals YFP+ recombined cells co-expressing nNOS (arrows, **g-i**), calbindin (arrows, **j-l**), or calretinin (arrows, **m-o**). Percentages of YFP+ cells co-expressing each inhibitory marker in the medial nucleus is shown in (**p**), with 78.6% (114/145) of recombined YFP+ cells in the medial nucleus are positive for nNOS, 50.8% (30/59) are positive for calbindin, and 19.1% (18/94) are positive for calretinin. Scale bar in (a) for (a-c); 250 µm. Scale bar in (d) for (d-o); 20 µm.](nihms103095f7){#F7}

![Electrophysiological properties of *Dbx1*-derived medial amygdala neurons\
DIC (**a**), fluorescent (**b**) and overlay (**c**) images of a typical YFP+ recombined medial amygdala neuron (arrows) with attached recording electrode. Live coronal slice indicating region of physiological recordings (**d**, asterisk). Firing patterns of a typical medial amygdala YFP+ recombined cell at threshold and sub-threshold (**e**) and supra-threshold (**f**) firing. Injected level of current for each trace is indicted below. Confocal image of biocytin filled cell (**g**) represented in **d** and **e** following physiological characterization. Note the fusiform-like dendritic arborization and the presence of sparsely spiny dendrites. Confocal image of biocytin filled cell conjugated to texas red following whole cell patch clamp recording is shown in (**h**). The current clamp trace of this cell is located in the upper right corner (scale bar: 200 ms horizontal, 20 mV vertical.) Fluorescent immunostaining for nNOS (green) reveals that this cell is also nNOS+ (yellow) (**i**).](nihms103095f8){#F8}
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